2011/10/11 12:00 - Asian Activities Report for October 11, 2011 includes: Allied Healthcare Group (ASX:AHZ) says today that its investee company Coridon Pty Ltd has successfully completed pre-clinical efficacy testing of its prototype Herpes Simplex Virus 2 vaccine with outstanding results; Universal Biosensors, Inc. (ASX:UBI) has commenced a new research and development project for Cilag GmbH International to determine the feasibility of an innovative blood glucose product to be used in the field of diabetes; Kalgoorlie Mining Company Limited (ASX:KMC) reports that recent drilling of the East Lode at the Bullant gold mine has intersected a spectacular high grade gold zone; Midas Resources Limited (ASX:MDS) will commence aircore drilling on a gold target south of the Intrepid Prospect at the Company's Lake Carey Project in Western Australia.
2011/09/30 12:00 - Asian Activities Report for September 30, 2011 includes: Neon Energy Limited (ASX:NEN) says today that the recently drilled Lombardi 19-27H development well in the North San Ardo oil field, onshore California, has been brought onstream; India Resources Limited (ASX:IRL) has signed a A$249M coal operations contract with Prism Cement Limited (BOM:500338) to develop and operate the first phase of Prism's Sial Ghoghri coal mine; Guildford Coal Limited (ASX:GUF) has upgraded its Exploration Targets at its Mongolian coal projects to 30Mt to 1.380Bt; Tissue Therapies Limited (ASX:TIS) will start the sales of VitroGro(R) for the treatment of chronic wounds in the UK and Europe during the second quarter of 2012; Biotron Limited (ASX:BIT) has commenced a human trial of its lead HIV drug candidate, BIT225; Circadian Technologies Limited (ASX:CIR) has submitted an investigational new drug application to the FDA to initiate clinical studies of VGX-100.
2011/09/28 12:02 - Asian Activities Report for September 28, 2011 includes: Fletcher Building Limited (ASX:FBU) said today that Iplex Pipelines has been awarded a A$120 million contract for the supply of polyethylene pipe; Integra Mining Limited (ASX:IGR) reported aircore drilling results from reconnaissance drilling in the Mt Monger area; African Iron Limited (ASX:AKI) provides an update on drilling activities at its 92%-owned Mayoko iron ore project in the Republic of Congo; Alchemia Limited (ASX:ACL) said today that its leading cancer product HA-Irinotecan has received very promising trial results; Tata Communications (BOM:500483) has become one of the few global carriers to extend its Global IP/VPN service offerings into Pakistan.
2011/07/28 12:02 - Asian Activities Report for July 28, 2011 includes: Novogen Limited's (ASX:NRT) subsidiary, Marshall Edwards, Inc.(NASDAQ:MSHL) announced the publication of results from a pre-clinical study of NV-128; Anatolia Energy Limited (ASX:AEK) announced an initial JORC Mineral Resource estimate for the Temrezli uranium prospect in Turkey; Waratah Resources Limited (ASX:WGO) has signed a binding Share Sale Agreement to acquire the Okanabora Project in the Republic of Congo; David Jones Limited (ASX:DJS) is launching a new brand campaign for Spring/Summer 2011.
2011/06/08 12:00 - Asian Activities Report for June 8, 2011 includes: Agenix (ASX:AGX) is on track to begin clinical trials in China for its lead Hepatitis B drug; Central Asia Resources Limited (ASX:CVR) reported gold resource increase to 124,000 ounces at Dalabai Gold Project; Tanami Gold NL (ASX:TAM) announced a further substantial increase in its gold Mineral Resources to 2.30 million ounces of gold; Corazon Mining Limited (ASX:CZN) confirmed the existence of a high-grade nickel/copper sulphide discovery at the Lynn Lake nickel sulphide project in Canada.
2011/05/02 12:00 - Asian Activities Report for May 2, 2011 includes: East Energy Resources Limited (ASX:EER) announced a maiden JORC Indicated Resource of 469 million tonnes of thermal coal at its Blackall Coal Project in Central Queensland; Oilex Limited (ASX:OEX) advises that the La Rocca-1 well on the WA-388-P permit offshore Western Australia was spudded on 30 April 2011; PT ANTAM (Persero) Tbk (ASX:ATM) reported strong corporate results for the first quarter of 2011; Bioniche Life Sciences Inc. (TSE:BNC) (ASX:BNC) opened its new Animal Health and Food Safety Vaccine Manufacturing Centre in Canada.
2011/04/06 12:00 - Asian Activities Report for April 6, 2011 includes: Motopia Limited's (ASX:MOT) subsidiary cBox Pty Ltd has been appointed as Business Wire's Australasian media distribution partner; MACA Limited (ASX:MLD) is to provide iron ore crushing and screening services for WPG Resources Limited (ASX:WPG); Rey Resources Limited (ASX:REY) announced an upgraded thermal coal Measured Resources at Duchess Paradise Project; Circadian Technologies Limited (ASX:CIR) said that VGX-100 significantly inhibits the growth and spread of various types of human tumour.
2011/02/24 12:10 - Australian Market Report of February 24, 2011 includes: Viralytics Limited (ASX:VLA) received a patent granting notice from China regarding the use of EVATAK(TM) as ovarian cancer treatment; Peak Resources Limited (ASX:PEK) reported the remaining assay results from the November-December 2010 RC and diamond drilling campaign; Ferrum Crescent Limited (ASX:FCR) has commenced drilling at the Moonlight Iron Ore Project in South Africa; United Uranium Limited (ASX:UUL) announced that No.1 Institute of Geology and Minerals of Shandong Province received investment approval; Gindalbie Metals Limited (ASX:GBG) announced today that the maiden shipment of iron ore from the Karara Iron Ore Project in Western Australia will occur within two months.
2011/02/21 12:21 - Australian Market Report of February 21, 2011 includes: Prima BioMed Limited (ASX:PRR) will commence the Phrase III clinical trial for what could be the world's first ovarian cancer immunotherapy vaccine; Redstone Resources Limited (ASX:RDS) announced further high grade copper results at the Tollu copper project in Western Australia; Western Desert Resources Limited (ASX:WDR) reported more high-grade iron ore results at Roper Bar Iron Ore Project in the Northern Territory; Canyon Resources Limited (ASX:CAY) updated on accelerated drilling program in Burkina Faso.
2011/02/07 13:30 - Australian Market Report of February 7, 2011 includes: Automotive Technology Group Limited (ASX:ATJ) announced that the company's Sprintex (R) Supercharger is the world's most efficient automotive supercharger system; Coal study highlights export grade thermal coal potential from Aviva Corporation Limited (ASX:AVA) Mmamantswe project in Botswana; EnviroGold Limited (ASX:EVG) has significantly strengthened its management in Latin America; Phosphagenics Limited (ASX:POH) announced collaboration to develop psoriasis drug in USA.
2011/01/31 13:30 - Australian Market Report of January 31, 2011 includes: China National Offshore Oil Company Limited (HKG:0883) (NYSE:CEO) has approved the Project Investment and the Overall Development Plan for the development of the three oil fields in China; Copper Strike Limited (ASX:CSE) signed agreements with China to fund multi-deposit project in North Queensland; Jupiter raises A$150 million to advance mining projects in South Africa and Australia; Viralytics Limited (ASX:VLA) (PINK:VRACY) has received Chinese notice for the grant of a patent involving of the use of CAVATAKTM RNA as an anti-cancer agent in human melanoma.
2011/01/11 09:13 - Cephalon, Inc. (NASDAQ:CEPH) and Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced positive interim results from Mesoblast's ongoing multi-center Phase 2 trial of its "off-the-shelf" proprietary adult stem cell product Revascor (TM) for patients with congestive heart failure.
2010/12/14 15:54 - Bounty Oil & Gas NL (ASX:BUY) (PINK:BYOGF) is pleased to announce that the "Ocean Patriot" semi submersible drill rig has been positioned at the New Seaclem 1 location, fixed with 8 anchors and has ballasted down. All operations have proceeded smoothly aided by calm seas.
2010/12/13 14:32 - MEC Resources Limited (ASX:MMR) investee company Advent Energy Ltd has advised on the current progress of the drilling activity at New Seaclem-1.
2010/12/09 12:43 - MEC Resources Limited (ASX:MMR) investee company Advent Energy Ltd (Advent) has advised that it (through wholly owned subsidiary Asset Energy Pty Ltd) has taken operational control of the Ocean Patriot semi-submersible drilling rig overnight.
2010/11/25 15:03 - MEC Resources (ASX:MMR) is pleased to announce that it has been informed by its investee company Advent Energy Ltd, that it has received a provisional date of Tuesday 7 December 2010 for the commencement of the operational handover of the Ocean Patriot Drilling semi-submersible rig for drilling the PEP11 project offshore Sydney.
2010/11/18 14:09 - MEC Resources (ASX:MMR) is pleased to announce that second independent report finds PEP11 New Seaclem-1 Well Gas "Highly Likely" MEC investee company, Advent Energy Ltd ("Advent") is pleased to advise that it has received and reviewed a report from global geoscientific and environmental consultants RPS Group (RPS) describing gas as "highly likely "at the target drilling depths for the New Seaclem-1 Well.
2010/11/16 14:43 - MEC Resources (ASX:MMR) is pleased to advise that Advent Energy has received approval from Industry & Investment NSW (I&I NSW) for the drilling of New Seaclem-1, offshore Newcastle, NSW. The NSW Department of Industry & Investment trades as Industry & Investment NSW (I&I NSW).
2010/11/09 17:28 - BPH Corporate Limited (ASX:BPH) is pleased to provide an update regarding its investee company Advent Energy Ltd's capital raising program and planned drilling activities within PEP11, offshore NSW.
2010/09/16 13:30 - Australian Market Report of September 16, 2010 inclues; Conquest Mining (ASX:CQT) has entered into an offtake contract for the sale of gold-silver-copper concentrate from its V2 deposit at Mt Carlton, Heemskirk Consolidated Limited (ASX:HSK) has announced the signing of an agreement with Conquest Mining Limited (ASX:CQT), Imugene Limited (ASX:IMU) today announced it has successfully completed a second trial of its Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine and Synthesis Energy Systems Inc. (NASDAQ:SYMX) and Coalworks Limited (ASX:CWK) today made a joint presentation titled "Production of Liquid Fuels from Oaklands Coal Utilizing U-GAS(R) and MTG Technologies".
2010/09/02 13:30 - Australian Market Report of September 2, 2010 includes; Empire Resources (ASX:ERL) enters into an option agreement with La Mancha Resources, Tanami Gold NL (ASX:TAM) reported further high grade results from its Central Tanami Project, the signing of a Native Title Mining Agreement for development of IronClad Mining's (ASX:IFE) Wilcherry Hill iron ore project and HealthLinx Limited (ASX:HTX) has finalised research agreements to begin the 220 patient study required for South Korea Food and Drug Administration (KFDA).
2010/08/09 13:31 - The Australian stock market opened lower on Monday, following mixed leads from overseas markets. In early trade, the S&P/ASX200 index was down 0.41 per cent, at 4547.4 points, while All Ordinaries had fallen 19 points, or 0.41 per cent, to 4567.3 points.
2010/08/04 13:31 - The Australian stock market opened lower on Wednesday, shedding gains after hitting a six-week high on the previous day. In early trade, S&P/ASX200 index was down 0.3 per cent, at 4558.1 points, while All Ordinaries index had fallen 0.28 per cent, to 4573.8 points. Financial and industrial stocks were down 0.5 per cent and the materials sector was 0.4 per cent lower.
2010/08/02 13:30 - The Australian share market begins the week with a slightly stronger opening without being affected by a flat lead from Wall Street. In early trade, Gold and Financial stocks were positive after the opening bell.
2010/07/13 10:21 - Results released today from a Phase III trial of the drug SCENESSE (R), conducted by Melbourne-based Clinuvel Pharmaceuticals Limited (ASX:CUV) (PINK:CLVLY), have shown that the drug has the ability to reduce and prevent painful phototoxic reactions experienced by patients with erythropoietic protoporphyria (EPP).
2010/07/08 10:36 - Melbourne's Clinuvel Pharmaceuticals Limited (ASX:CUV) (PINK:CLVLY) today signed with a commercial US partner to manufacture its world's first photoprotective drug, SCENESSE (R), under an exclusive arrangement. Following eight years of development, Clinuvel has selected Surmodics, Inc. (NASDAQ:SRDX), a leading Minnesota-based provider of proprietary drug delivery technologies to the healthcare industry, as its first manufacturing partner.
2009/02/18 11:50 - Ventracor Limited (ASX:VCR)(PINK:VTCRY) is responding to an article that appeared in today's "The Australian" newspaper, which in the Company's view makes incorrect and misleading allegations regarding the Company and its product the VentrAssist(R) Left Ventricular Assist Device (LVAD).
2008/05/06 14:59 - Ventracor Limited (ASX:VCR)(US:VTCRY) today announced that there have now been more than 250 patient implants of the VentrAssist(R) Left Ventricular Assist Device (LVAD).
2008/04/14 12:56 - Ventracor Limited (ASX:VCR)(US:VTCRY) today released the clinical results of the US Feasibility Trial of the VentrAssist(R) Left Ventricular Assist Device (LVAD). The results were presented on Saturday 12 April at the annual meeting of the International Society of Heart and Lung Transplantation (ISHLT) in Boston by Dr. Andrew Boyle, Assistant Professor of Medicine at the University of Minnesota Medical School, in Minneapolis MN.
2008/04/03 13:55 - Ventracor Limited (ASX: VCR)(PNK: VTCRY) CEO, Peter Crosby Letter to Shareholders
2008/04/03 12:35 - Leading Australian developer and manufacturer of prosthetic implants and medical devices, Advanced Surgical Design and Manufacture Limited (ASX: AMT) announces that this Thursday's episode of Catalyst (ABC TV) will feature the Limb Saving clinical trial currently being undertaken by AllVascular Pty Ltd and utilising the PAD access device developed with Advanced Surgical and exclusively manufactured by Advanced Surgical.
2008/04/03 10:51 - Ventracor Limited (ASX: VCR)(PNK: VTCRY) announced today changes to the Board of Directors. John Massey has retired as a Director and Chairman of the Board. John Ward has been elected Chairman of the Board of Directors, and William Curran takes on the role of Chairman of the Audit, Risk and Compliance Committee.
2008/03/17 09:52 - Ventracor Limited (ASX: VCR)(ADR: VTCRY) announced today that the US Food and Drug Administration (FDA) has granted unconditional approval for the US Destination Therapy Trial of the VentrAssist Left Ventricular Assist Device (LVAD).
2008/03/13 11:13 - Ventracor (ASX: VCR) announced today the appointment of Professor Mariell Jessup as Cardiology Principal Investigator of the US Destination Therapy Trial of the VentrAssist Left Ventricular Assist Device (LVAD).
2008/02/15 12:39 - In a landmark study electronically published today in the American Journal of Respiratory and Critical Care Medicine, a blood test for detecting TB infection, QuantiFERON-TB Gold (QFT), has been shown to be six times more accurate than the conventional tuberculin skin test (TST) at predicting which tuberculosis (TB)-exposed individuals will go on to develop TB disease. This study has important implications for the worldwide effort to eradicate TB, as accurately indentifying TB-infected individuals allows health authorities to treat them before they develop disease, and the greater accuracy of the new test makes this more efficient as well as cheaper and safer.
2008/02/11 14:09 - Ventracor (ASX: VCR) has implanted the 200th patient with its VentrAssist(tm) Left Ventricular Assist Device (LVAD)
2007/12/19 09:42 - Ventracor (ASX: VCR) today announced CE Marking approval for the next version of the VentrAssist(tm) left ventricular assist device (LVAD) which allows it to be marketed and sold in Europe.
2007/12/18 14:04 - Ventracor (ASX: VCR) today announced US Food & Drug Administration (FDA) approval to use the new version of its VentrAssist(tm) left ventricular assist device (LVAD) in its US clinical trial program.
2007/12/17 15:39 - An Australian invention designed to decrease the likelihood of patients remembering parts of their surgery and improve their recovery from anaesthesia has just completed a further stage of clinical trials at Royal Melbourne Hospital. The positive results following the completion of this trial are a significant development for BioPharmica's investee Cortical Dynamics.
2007/12/17 15:22 - Cellestis Limited (ASX: CST) is pleased to announce it has been advised by the Korean Food and Drug Administration (KFDA) that QuantiFERON(R)-TB Gold In-Tube has received regulatory approval in the Republic of Korea (South Korea); allowing sale of the test in the Republic of Korea.
Biotech